What factors drove the changes in Zepp Health's revenue and profit?

What is the market's earnings forecast for Zepp Health next quarter?

What is Zepp Health's latest dividend and current dividend yield?

What were the key takeaways from Zepp Health's earnings call?

What guidance did Zepp Health's management provide for the next earnings period?

What is the revenue and EPS growth rate for Zepp Health year over year?

Did Zepp Health beat or miss consensus estimates last quarter?

What were the key takeaways from Zepp Health’s earnings call?

- **Revenue Surge**: 78.5% YoY growth driven by premium product launches.
- **Gross Margin Expansion**: 38.2% Q3, targeting further improvement.
- **Supply Chain Resilience**: Helio Strap constraints offset by T-Rex 3 Pro momentum.
- **Q4 Guidance**: $82-86M revenue, 38-45% YoY growth.
- **Cash Flow Strength**: $103M cash balance, operational breakeven achieved.


**【CEO Summary Section】**
- **Revenue Growth**: Q3 2025 revenue surged 78.5% YoY to $75.8M, driven by T-Rex 3 Pro and Balance 2/Helio Strap demand.
- **Product Launch Momentum**: T-Rex 3 Pro 48mm launched at UTMB; 44mm version debuted Oct 25. Entry-level Bip 6/Active 2 maintained steady sales.
- **Gross Margin Expansion**: Sequentially improved to 38.2% (from 36.2%), supported by premium product mix and cost control.
- **Q4 Outlook**: Revenue guidance $82-86M (38-45% YoY growth), fueled by holiday season demand.

**【CFO Financial Commentary】**
- **Supply Chain Challenges**: Helio Strap constrained by memory chip shortages; T-Rex 3 Pro supply adjustments.
- **Cost Management**: Operating expenses stable at $28.6M (37.7% of sales), with R&D/Mktg spend optimized for ROI.
- **Cash Flow Strength**: Q3 cash balance $103M (vs. $95M Q2), driven by operational efficiency.
- **Debt Optimization**: Retired $64.5M debt since 2023, refinanced short-term debt into long-term instruments.

**【Q&A Key Highlights】**
- **Helio Strap Supply Constraints**: Memory chip shortages and typhoon-related delays impacted Q3 shipments.
- **Channel Strategy**: Online growth (Amazon/Zepp.com) outpaces offline expansion; T-Rex 3 Pro 44mm prioritized for online sales.
- **Holiday Season Demand**: T-Rex 3 Pro 48mm outperformed expectations, with 44mm version gaining traction.
- **Price Growth**: Q4 ASPs expected to support margin expansion through selective promotions.


Zepp Health Corporation (ZEPP) Q3 2025 Earnings Call Transcript

- **Revenue Milestone**: 46% YoY growth to $59.4 million, first YoY increase since Q2 2021.
- **Product Success**: Helio Strap recognized as top heart rate monitor; Balance 2 expands premium lineup.
- **Q3 Guidance**: $72-76 million revenue, 70-79% YoY growth driven by new launches and seasonal demand.
- **Gross Margin Expansion**: Expected improvement in H2 2025 with higher-margin products like Balance 2.
- **Tariff Mitigation**: Vietnam production eliminates U.S. tariffs, reducing cost pressures.
- **AI Integration**: Zepp OS 5.0 with OpenAI and Gemini enhances training insights and user experience.

**【CEO Summary Section】**
- **Revenue Growth**: Q2 2025 revenue reached $59.4 million, a 46% year-over-year increase, marking the first YoY growth since Q2 2021.
- **Product Launches**: Key launches include the T-Rex 3 (premium outdoor smartwatch), Balance 2 (flagship multisport device), and Helio Strap (screen-free fitness tracker). The Balance 2, priced at $299, features advanced sports modes and integrates AI-driven training insights.
- **Market Performance**: Amazon Prime Day sales surged 60% in EMEA and ranked second in the U.S. for wearable brands. The Bip 6 and Active 2 series saw steady growth across global markets.
- **Strategic Initiatives**: Expansion of the Amazfit Athletes team with NFL star Derrick Henry and Ultra Runner Rod Farvard. Zepp OS 5.0 integrates AI from OpenAI and Google Gemini, enhancing training and recovery features.
- **Supply Chain**: Diversified manufacturing across China, Vietnam, and potential NAFTA expansion to mitigate tariff risks.

**【CFO Financial Commentary】**
- **Revenue and Margins**: Q2 gross margin of 36.2% (flat Q/Q, down YoY due to lower-margin entry-level products). Q3 revenue guidance: $72-76 million (70-79% YoY growth).
- **Cost Management**: Operating expenses at $26 million (Q2 2024: $25 million). R&D investment at $10.3 million (4.2% YoY increase) for new technologies.
- **Financial Health**: Cash balance of $95 million (Q1 2025: $103 million) with debt restructuring reducing near-term liquidity pressures.
- **Share Repurchase**: Reaffirmed commitment to 2025 share buyback program, reflecting confidence in long-term growth.

**【Q&A Highlights】**
- **Share Price Drivers**: Success of Helio Strap and Balance 2, undervaluation relative to peers, and strong Amazon Prime Day performance.
- **Product Pipeline**: Q3 launches include a flagship device, with pipeline comparable to 2024 H2. Helio Strap faces supply constraints but expects Q3 resolution.
- **Tariff Mitigation**: 0% tariffs on Vietnam-to-U.S. shipments vs. 25% from China, offsetting tariff headwinds through operational efficiency.
- **Gross Margin Outlook**: Medium-term target above 40% as premium products like Balance 2 gain market share.
- **Helio Strap Contribution**: Priced at $99 with healthy gross margin, expected to scale with supply improvements.

Zepp Health Corporation (ZEPP) Q2 2025 Earnings Call Transcript

- **Revenue Revival**: 10% YoY growth in Amazfit revenue, signaling strategic turnaround.
- **Market Strength**: 23.3% smartwatch share in Italy, outperforming peers in key European markets.
- **Tech Leap**: Zepp OS 4.5 with OpenAI enhances user interaction and health tracking accuracy.
- **Financial Resilience**: Gross margin expansion to 37.3%, with $104M cash cushion for growth initiatives.
- **Growth Catalysts**: Q2 revenue up 23-35%, driven by new products and cost efficiency.

**【CEO Key Highlights】**
- **Revenue Recovery**: Amazfit revenue grew 10% YoY, marking the first growth post a two-year transformation period.
- **Market Expansion**: U.S. revenue accounts for 15% of total, with strategic diversification into Vietnam and NAFTA to mitigate tariffs.
- **Product Success**: Active 2 and Bip 6 achieved top 10 rankings on Amazon, with 23.3% market share in Italy (vs. Apple's 42%).
- **Innovation**: Zepp OS 4.5 integrates OpenAI for voice control and AI-driven health tracking, enhancing user engagement.
- **Brand Momentum**: Athlete partnerships (e.g., Jasmine Paolini) and HYROX events strengthen brand visibility in fitness communities.

**【CFO Financial Breakdown】**
- **Q1 2025 Results**: 
  - Revenue aligned with guidance, 10.2% YoY growth in Amazfit products.
  - Gross Margin: 37.3% (38.4% ex-tariffs), up from Q4 2024 and Q1 2024.
  - Operating Expenses: $31.5M (QoQ +7%, YoY +15%), driven by R&D and marketing investments.
  - Cash Balance: $104M, with $67.8M debt retired year-to-date.
- **Tariff Impact**: Full-year tariff cost ~$2-3M, offset by operational efficiency gains.
- **Q2 Outlook**: Revenue $50-55M (23-35% YoY growth), with focus on new product launches and cost optimization.

**【Q&A Key Takeaways】**
- **Tariff Strategy**: Vietnam production mitigates 10% U.S. tariffs; NAFTA expansion planned for long-term resilience.
- **Cost Management**: Q2 OpEx expected to drop to $25-27M, driven by reduced marketing spend and FX hedging.
- **Product Pipeline**: Multiple new products in 2025, including China-focused launches, to sustain growth momentum.
- **Competitive Pricing**: No immediate price hikes, but regional adjustments may occur based on market dynamics.

Zepp Health Corporation (ZEPP) Q1 2025 Earnings Call Transcript

- **40% QoQ revenue growth** in Q4 2024, up from 26.2% to 39% full year gross margin
- **T-Rex 3 AI smartwatch** achieves 6-month success with industry-leading specs
- **Amazfit Active 2** poised for explosive Q2 growth at $100 price point
- $112M cash war chest to fuel AI-driven product expansion
- Strategic partnerships with Olympic athletes and HYROX sports ecosystem
- Differentiated AI health ecosystem with food scanner and app integration

**【CEO Opening Remarks】**
- Q4 2024 revenue grew 40% quarter-over-quarter, exceeding guidance despite macroeconomic challenges.
- Full year 2024 gross margin improved to 39% (vs. 26.2% in 2023), driven by high-margin AI-enabled products.
- $112M cash on hand provides runway for strategic investments.

**【Product Highlights】**
1. **T-Rex 3 Smartwatch**: 
   - 6-month post-launch success with strong user activation
   - Features AI-powered Zepp OS 4.0/GPT 4.0 integration
   - Military-grade durability, 100-hour battery life, offline mapping
   - Positioned as industry leader in adventure smartwatches

2. **Amazfit Active 2**: 
   - $100 price point with advanced health sensors and AI coaching
   - CES 2025 launch with strong media reviews
   - Expected explosive Q2 growth in EMEA/USA

3. **Amazfit Bip 6 Series**: 
   - Entry-level value proposition
   - Scaling production for Q2 shipments in key markets

4. **AI Health Ecosystem Expansion**: 
   - Amazfit Vital food scanner with AI image recognition
   - Free Zepp app food logging feature in Europe/North America
   - Exploring DeepSeek for scalable food analysis

**【Market Expansion】**
- Strategic athlete partnerships (Gabby Thomas, Jasmine Paolini)
- HYROX sports ecosystem integration (only smartwatch brand supporting HYROX)
- Gained offline retail shelf space in US/Europe replacing competitors

**【2025 Strategy】**
- Dual-track growth: 
   - Entry-level (Active 2/Bip 6) for market share
   - Mid/high-end (T-Rex series) for profitability
- Differentiate through emerging sports support and AI health ecosystem


ZEPP

ZEPP fundamentals

Earnings Call

You can ask Aime